Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 05, 2023 07:00 ET | Source: BiondVax Pharmaceuticals Ltd.

BiondVax signs exclusive license agreement for development and commercialization of a novel anti-IL-17 antibody for treatment of autoimmune and inflammatory diseases including psoriasis

Broad-based collaboration with Max Planck and University Medical Center Gottingen yields attractive anti-IL-17 VHH antibodies (NanoAbs); includes exclusive worldwide license for all potential...
June 11, 2019 08:30 ET | Source: Q2Earth, Inc

Q2Earth Signs Exclusive Worldwide License with Agrarian Technologies for Organic Bio-Stimulants

Natural formula to be sold by Q2Earth can replace chemical fertilizers and enhance value of soil and mulch products through proprietary processes Palm Beach, FL, June 11, 2019 (GLOBE NEWSWIRE) --...